PER 1.41% 7.0¢ percheron therapeutics limited

Ann: ANP Updates on US Regulatory Plans for ATL1102 in DMD, page-124

  1. 1,703 Posts.
    lightbulb Created with Sketch. 605
    Sounds a bit antsy I must confess. The market has spoken - rightly or wrongly - and it has critically judged the Ann as being a big negative. Another miss-step I think was having quoted attribution to our highly rated new Chair. Diamond should have owned this announcement & left clean air for GC.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.